FDA Seeks Comment On Circumstances For Delaying Denying Limiting Or Refusing An Inspection

The FDA has released for public comment a proposed draft guidance, Circumstances that Constitute Delaying, Denying, Limiting, or Refusing a Drug or...

Related Keywords

Mark Durivage ,Drug Administration Safety ,Health Administration ,Office Of Strategic Planning ,Drug Administration ,Office Of Regulatory Affairs ,Quality Systems Compliance ,Constitute Delaying ,Device Inspection Revision ,Drug Inspection ,Innovation Act ,Occupational Safety ,Dockets Management ,Regulatory Affairs ,Strategic Planning ,Operational Policy ,